Afuco™ Anti-Frizzled Receptor ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-880) (CAT#: AFC-TAB-880)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human Frizzled receptor. It is a monoclonal antibody designed for the treatment of cancer.
Specific Inquiry
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Human
- Type
- ADCC enhanced antibody
- Species Reactivity
- Human
- Applications
- Neut, ELISA, IF, IP, FuncS, FC
- Conjugate
- Unconjugated
- Generic Name
- Vantictumab
- Related Disease
- Solid tumors
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- FZD1; frizzled family receptor 1; frizzled (Drosophila) homolog 1, frizzled 1, seven transmembrane spanning receptor, frizzled homolog 1 (Drosophila); frizzled-1; DKFZp564G072; frizzled; Drosophila; homolog of; 1; Wnt receptor
- Gene ID
- 8321
- UniProt ID
- Q9UP38
Related Resources
Please refer to Vantictumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Vantictumab.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Vantictumab"
Anti-Human Frizzled receptor Recombinant Antibody (Vantictumab)Recombinant human monoclonal antibody expressed in CHO binding to human Frizzled receptor. Vantictumab is a monoclonal antibody designed for the treatment of cancer.
DrugMonitor™ Anti-Vantictumab Antibody (VS-1224-YC1274)Vantictumab has been used in trials for treating solid tumors and pancreatic cancer, including stage IV pancreatic cancer. The DrugMonitor™ Anti-Vantictumab Antibody (VS-1224-YC1274) is an anti-drug antibody (ADA) against Vantictumab. This drug-based antibody is raised in mice immunized with the Vantictumab. The anti-Vantictumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Vantictumab in samples.
See other products for "Frizzled receptor"
Select a product category from the dropdown menu below to view related products.
Please select product type
Single Domain Antibody Products
Human Antibody Products
| CAT | Product Name | Application | Type |
|---|---|---|---|
| NAB-1026-sdAb | Recombinant Anti-Human Frizzled receptor VHH Single Domain Antibody | IP, FC, ChiP, Neut | Llama VHH |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-880. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: WB, FuncS, IF, Neut, ELISA, FC, IP
Application:
Application: ELISA, SPR, Inhib, FuncS
Application: ELISA, IHC, FC, IP, IF, FuncS
-1.png)
Application: ELISA
-1.png)
Application: ELISA, WB
Application: ELISA, FuncS
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
